Home>>5-fluoro PB-22 3-carboxyindole metabolite

5-fluoro PB-22 3-carboxyindole metabolite

Catalog No.GC18415

5-fluoro PB-22 3-carboxyindole metabolite is an analytical reference standard that is structurally categorized as a synthetic cannabinoid.

Products are for research use only. Not for human use. We do not sell to patients.

5-fluoro PB-22 3-carboxyindole metabolite Chemical Structure

Cas No.: 1432794-98-3

Size Price Stock Qty
100µg
$205.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

5-fluoro PB-22 3-carboxyindole metabolite is an analytical reference standard that is structurally categorized as a synthetic cannabinoid.[1]  It is a metabolite of 5-fluoro PB-22 , in which the 8-hydroxyquinoline group characteristic of PB-22 analogs has been removed. [2] The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.

Reference:
[1]. Davies, B.B., Bayard, C., Larson, S.J., et al. Retrospective analysis of synthetic cannabinoid metabolites in urine of individuals suspected of driving impaired. J. Anal. Toxicol. 40(2), 89-96 (2016).
[2]. Wohlfarth, A., Gandhi, A.S., Pang, S., et al. Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry. Anal. Bioanal. Chem. 406(6), 1763-1780 (2014).

Reviews

Review for 5-fluoro PB-22 3-carboxyindole metabolite

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 5-fluoro PB-22 3-carboxyindole metabolite

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.